Interventional Cardiology Devices Market is estimated to be US$ 319.8 Billion by 2034 with a CAGR of 7.5% during the forecast period

Interventional cardiology may be a branch of cardiology that deals specifically with the catheter based treatment of structural heart diseases. Many procedures are often performed on the guts by catheterization. This most ordinarily involves the insertion of a sheath into the arteria femoralis (but, in practice, any large peripheral artery or vein) and cannulating the guts under X-ray visualization (most commonly fluoroscopy). The arteria radialis can also be used for cannulation; this approach offers several advantages, including the accessibility of the artery in most patients, the straightforward control of bleeding even in anticoagulated patients, the enhancement of comfort because patients are capable of sitting up and walking immediately following the procedure, and therefore the near absence of clinically significant sequelae in patients with a traditional Allen test. Interventional Cardiology Device Market was valued at US$ 165.2 Billion in 2024 and is projected to grow at a CAGR of 7.5% to reach US$ 319.8 Billion by 2034.

The report "Interventional Cardiology Devices Market, By Type (Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Other), and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) - Trends, Analysis, and Forecast till 2034”

Key Highlights:

• In 2020, Edward Lifesciences Corporation (US) has received Chinese regulatory approval for the SAPIEN 3 Transcatheter Heart Valve for the treatment of patients affected by severe, symptomatic stenosis (AS) who are unable to undergo heart surgery
• In 2019, Medtronic (US) has received US FDA approval for its Next-Generation Evolut PRO TAVR System for the treatment of symptomatic severe stenosis in patients

Analyst View:

Rising prevalence of lifestyle habits like a growing number of smokers, rising incidence rates of obesity, and dietary irregularities are liable for the expansion within the prevalence of major cardiovascular diseases across the planet fuelling interventional cardiology device industry growth. Each year, 170,000 people die from heart and circulatory diseases within the UK. Such a huge patient population and therefore the high death rate is predicted to extend the demand for interventional cardiology devices within the coming years.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Interventional Cardiology Devices Market, By Type (Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Other), and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) - Trends, Analysis, and Forecast till 2034”

Key Market Insights from the report:

Interventional Cardiology Device Market was valued at US$ 165.2 Billion in 2024 and is projected to grow at a CAGR of 7.5% to reach US$ 319.8 Billion by 2034.The Interventional Cardiology Devices Market is segmented into types, and region.

• On the basis of type, the Global Interventional Cardiology Devices Market is segmented into Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Other.
• Based on region the Global Interventional Cardiology Devices Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is estimated to hold dominating position in the Global Interventional Cardiology Devices Market during the forecast period.

Competitive Landscape:

The Key players in the interventional cardiology devices market includes, Cordis Corporation, Abbott Laboratories, Medtronic, Inc., Terumo Medical Corporation, Braun Melsungen AG, Boston Scientific Coprporation, Terumo Corporation, Cordis Corporation, Biosensors International Group, Ltd., and Biotronik, Inc.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

To know more

Contact Us:

Sales

Prophecy Market Insights

U.S: 1 860 531 2574

RoW: 91 7775049802

Email- [email protected]

Website- www.prophecymarketinsights.com